{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T01:27:38Z","timestamp":1792286858942,"version":"4.4.0"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T00:00:00Z","timestamp":1658534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To determine clinical practice variation and identify knowledge gaps in antibiotic treatment of Staphylococcus aureus bacteraemia (SAB).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A web-based survey with questions addressing antibiotic treatment of SAB was distributed through the ESGAP network among infectious disease specialists, clinical microbiologists and internists in Croatia, France, Greece, the Netherlands and the UK between July 2021 and November 2021.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total number of 1687 respondents opened the survey link, of whom 677 (40%) answered at least one question. For MSSA and MRSA bacteraemia, 98% and 94% preferred initial monotherapy, respectively. In patients with SAB and non-removable infected prosthetic material, between 80% and 90% would use rifampicin as part of the treatment. For bone and joint infections, 65%\u201377% of respondents would consider oral step-down therapy, but for endovascular infections only 12%\u201332% would. Respondents recommended widely varying treatment durations for SAB with different foci of infection. Overall, 48% stated they used 18F-fluorodeoxyglucose positron emission tomography\/CT (18F-FDG-PET\/CT) to guide antibiotic treatment duration. Persistent bacteraemia was the only risk factor for complicated SAB that would prompt a majority to extend treatment from 2 to 4\u20136\u2005weeks.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>This survey in five European countries shows considerable clinical practice variation between and within countries in the antibiotic management of SAB, in particular regarding oral step-down therapy, choice of oral antibiotic agents, treatment duration and use of 18F-FDG-PET\/CT. Physicians use varying criteria for treatment decisions, as evidence from clinical trials is often lacking. These areas of practice variation could be used to prioritize future studies for further improvement of SAB care.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jac\/dkac237","type":"journal-article","created":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T08:09:25Z","timestamp":1658563765000},"page":"2827-2834","source":"Crossref","is-referenced-by-count":17,"title":["Current clinical practice in antibiotic treatment of <i>Staphylococcus aureus<\/i> bacteraemia: results from a survey in five European countries"],"prefix":"10.1093","volume":"77","author":[{"given":"D T P","family":"Buis","sequence":"first","affiliation":[{"name":"Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Internal Medicine, Division of Infectious Diseases, Amsterdam Institute for Infection and Immunity , De Boelelaan 1117 , Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J M","family":"Prins","sequence":"additional","affiliation":[{"name":"Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Internal Medicine, Division of Infectious Diseases, Amsterdam Institute for Infection and Immunity , De Boelelaan 1117 , Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Betica-Radic","sequence":"additional","affiliation":[{"name":"General Hospital Dubrovnik, Department of Infectious Diseases, University of Dubrovnik , Dubrovnik , Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M G J","family":"de Boer","sequence":"additional","affiliation":[{"name":"Leiden University Medical Center, Department of Infectious Diseases , Leiden , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Ekkelenkamp","sequence":"additional","affiliation":[{"name":"UMC Utrecht, Department of Medical Microbiology , Heidelberglaan 100 , 3584 CX Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Kofteridis","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine & Infectious Diseases, University Hospital of Heraklion , Heraklion , Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Peiffer-Smadja","sequence":"additional","affiliation":[{"name":"Infectious Disease Department, Bichat-Claude Bernard Hospital, Assistance-Publique H\u00f4pitaux de Paris , Paris , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Schouten","sequence":"additional","affiliation":[{"name":"Department of Intensive Care Medicine, Radboudumc , Nijmegen , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Spernovasilis","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine & Infectious Diseases, University Hospital of Heraklion , Heraklion , Greece"},{"name":"Department of Infectious Diseases, German Oncology Center , Limassol , Cyprus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3617-5411","authenticated-orcid":false,"given":"P","family":"Tattevin","sequence":"additional","affiliation":[{"name":"Infectious Diseases and Intensive Care Unit, Pontchaillou University Hospital , Rennes , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2397-0125","authenticated-orcid":false,"given":"J","family":"ten Oever","sequence":"additional","affiliation":[{"name":"Radboud University Medical Center, Department of Internal Medicine and Radboud Center for Infectious Diseases , Geert Grooteplein Zuid 10 , Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K C E","family":"Sigaloff","sequence":"additional","affiliation":[{"name":"Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Internal Medicine, Division of Infectious Diseases, Amsterdam Institute for Infection and Immunity , De Boelelaan 1117 , Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,7,23]]},"reference":[{"key":"2022122818211411000_dkac237-B1","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1128\/CMR.00134-14","article-title":"Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management","volume":"28","author":"Tong","year":"2015","journal-title":"Clin Microbiol Rev"},{"key":"2022122818211411000_dkac237-B2","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jinf.2013.10.015","article-title":"Staphylococcus aureus bloodstream infection: a pooled analysis of five prospective, observational studies","volume":"68","author":"Kaasch","year":"2014","journal-title":"J Infect"},{"key":"2022122818211411000_dkac237-B3","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1093\/cid\/ciab632","article-title":"Prediction rules for ruling out endocarditis in patients with Staphylococcus aureus bacteremia","volume":"74","author":"van der Vaart","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2022122818211411000_dkac237-B4","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1001\/jamainternmed.2017.3958","article-title":"Association of evidence-based care processes with mortality in staphylococcus aureus bacteremia at Veterans Health Administration hospitals, 2003-2014","volume":"177","author":"Goto","year":"2017","journal-title":"JAMA Intern Med"},{"key":"2022122818211411000_dkac237-B5","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1001\/jama.2014.9743","article-title":"Clinical management of Staphylococcus aureus bacteremia: a review","volume":"312","author":"Holland","year":"2014","journal-title":"JAMA"},{"key":"2022122818211411000_dkac237-B6","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1093\/cid\/ciq146","article-title":"Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2022122818211411000_dkac237-B7","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/jac\/dkr450","article-title":"Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: a report of the Working Party of the British Society for Antimicrobial Chemotherapy","volume":"67","author":"Gould","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"2022122818211411000_dkac237-B8","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1093\/cid\/civ482","article-title":"2015 Infectious Diseases Society of America (IDSA) Clinical practice guidelines for the diagnosis and treatment of native vertebral osteomyelitis in adults","volume":"61","author":"Berbari","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2022122818211411000_dkac237-B9","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1161\/CIR.0000000000000296","article-title":"Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association","volume":"132","author":"Baddour","year":"2015","journal-title":"Circulation"},{"key":"2022122818211411000_dkac237-B10","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/cid\/ciy1144","article-title":"Clinical practice variation among adult infectious disease physicians in the management of Staphylococcus aureus bacteremia","volume":"69","author":"Liu","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2022122818211411000_dkac237-B11","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.cmi.2020.08.044","article-title":"Comparative outcomes of cefazolin versus antistaphylococcal penicillins in methicillin-susceptible Staphylococcus aureus infective endocarditis: a post hoc analysis of a prospective multicentre French cohort study","volume":"27","author":"Lecomte","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"2022122818211411000_dkac237-B12","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.cmi.2017.07.001","article-title":"Comparative outcomes of cefazolin versus nafcillin for methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective multicentre cohort study in Korea","volume":"24","author":"Lee","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"2022122818211411000_dkac237-B13","doi-asserted-by":"crossref","first-page":"e023151","DOI":"10.1136\/bmjopen-2018-023151","article-title":"Efficacy of cloxacillin versus cefazolin for methicillin-susceptible Staphylococcus aureus bacteraemia (CloCeBa): study protocol for a randomised, controlled, non-inferiority trial","volume":"8","author":"Burdet","year":"2018","journal-title":"BMJ Open"},{"key":"2022122818211411000_dkac237-B14","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.cmi.2021.01.027","article-title":"Re: \u2018Comparative outcomes of cefazolin versus anti-staphylococcal penicillins in methicillin-susceptible Staphylococcus aureus infective endocarditis: a post-hoc analysis multicentre French cohort study\u2019 by Lecomte et al","volume":"27","author":"Buis","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"2022122818211411000_dkac237-B15","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1093\/eurheartj\/ehv319","article-title":"2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM)","volume":"36","author":"Habib","year":"2015","journal-title":"Eur Heart J"},{"key":"2022122818211411000_dkac237-B16","doi-asserted-by":"crossref","first-page":"e249","DOI":"10.1093\/cid\/ciaa1040","article-title":"Is rifampin use associated with better outcome in staphylococcal prosthetic valve endocarditis? A multicenter retrospective study","volume":"72","author":"Le Bot","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2022122818211411000_dkac237-B17","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1001\/jama.279.19.1537","article-title":"Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group","volume":"279","author":"Zimmerli","year":"1998","journal-title":"JAMA"},{"key":"2022122818211411000_dkac237-B18","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1001\/archinte.168.8.805","article-title":"Adjunctive use of rifampin for the treatment of Staphylococcus aureus infections: a systematic review of the literature","volume":"168","author":"Perlroth","year":"2008","journal-title":"Arch Intern Med"},{"key":"2022122818211411000_dkac237-B19","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S0140-6736(17)32456-X","article-title":"Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial","volume":"391","author":"Thwaites","year":"2018","journal-title":"Lancet"},{"key":"2022122818211411000_dkac237-B20","doi-asserted-by":"crossref","first-page":"ofaa151","DOI":"10.1093\/ofid\/ofaa151","article-title":"A narrative review of early oral stepdown therapy for the treatment of uncomplicated Staphylococcus aureus bacteremia: yay or nay?","volume":"7","author":"Dagher","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"2022122818211411000_dkac237-B21","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/jac\/dky452","article-title":"Sequential intravenous-to-oral outpatient antibiotic therapy for MRSA bacteraemia: one step closer","volume":"74","author":"Jorgensen","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"2022122818211411000_dkac237-B22","doi-asserted-by":"crossref","first-page":"h2219","DOI":"10.1136\/bmj.h2219","article-title":"Trimethoprim-sulfamethoxazole versus vancomycin for severe infections caused by meticillin resistant Staphylococcus aureus: randomised controlled trial","volume":"350","author":"Paul","year":"2015","journal-title":"BMJ"},{"key":"2022122818211411000_dkac237-B23","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/cid\/ciy916","article-title":"Early oral switch to linezolid for low-risk patients with Staphylococcus aureus bloodstream infections: a propensity-matched cohort study","volume":"69","author":"Willekens","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2022122818211411000_dkac237-B24","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1056\/NEJMoa1808312","article-title":"Partial oral versus intravenous antibiotic treatment of endocarditis","volume":"380","author":"Iversen","year":"2019","journal-title":"N Engl J Med"},{"key":"2022122818211411000_dkac237-B25","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s13063-020-4102-0","article-title":"Protocol update for the SABATO trial: a randomized controlled trial to assess early oral switch therapy in low-risk Staphylococcus aureus bloodstream infection","volume":"21","author":"Kaasch","year":"2020","journal-title":"Trials"},{"key":"2022122818211411000_dkac237-B26","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1001\/archinte.163.17.2066","article-title":"Clinical identifiers of complicated Staphylococcus aureus bacteremia","volume":"163","author":"Fowler","year":"2003","journal-title":"Arch Intern Med"},{"key":"2022122818211411000_dkac237-B27","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1093\/cid\/ciz275","article-title":"A survey of infectious diseases and microbiology clinicians in Australia and New Zealand about the management of Staphylococcus aureus bacteremia","volume":"69","author":"Tong","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2022122818211411000_dkac237-B28","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/s13063-019-3357-9","article-title":"Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia (SAB7): study protocol for a randomized controlled trial","volume":"20","author":"Thorlacius-Ussing","year":"2019","journal-title":"Trials"},{"key":"2022122818211411000_dkac237-B29","doi-asserted-by":"crossref","first-page":"e3859","DOI":"10.1093\/cid\/ciaa929","article-title":"Integration of FDG-PET\/CT in the diagnostic workup for Staphylococcus aureus bacteremia: a prospective interventional matched-cohort study","volume":"73","author":"Ghanem-Zoubi","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2022122818211411000_dkac237-B30","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.2967\/jnumed.117.191981","article-title":"(18)F-FDG PET\/CT optimizes treatment in Staphylococcus aureus bacteremia and is associated with reduced mortality","volume":"58","author":"Berrevoets","year":"2017","journal-title":"J Nucl Med"},{"key":"2022122818211411000_dkac237-B31","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s12149-020-01449-8","article-title":"Expert consensus on clinical application of FDG PET\/CT in infection and inflammation","volume":"34","author":"Li","year":"2020","journal-title":"Ann Nucl Med"},{"key":"2022122818211411000_dkac237-B32","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/imj.14117","article-title":"Access, knowledge and experience with fluorodeoxyglucose positron emission tomography\/computed tomography in infection management: a survey of Australia and New Zealand infectious diseases physicians and microbiologists","volume":"49","author":"Douglas","year":"2019","journal-title":"Intern Med J"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/77\/10\/2827\/48439591\/dkac237.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/77\/10\/2827\/48439591\/dkac237.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T21:34:29Z","timestamp":1672263269000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/77\/10\/2827\/6648977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,23]]},"references-count":32,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,7,23]]},"published-print":{"date-parts":[[2022,9,30]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkac237","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,10,3]]},"published":{"date-parts":[[2022,7,23]]}}}